The basis of the enzyme therapy for cancer was originally discovered by a Scottish embryologist, Dr. John Beard, who back in 1910 saw how cancer patients he was managing would go into remission after receiving porcine pancreatic enzymes. The theory is based upon view that cancer cells produce a hormone called Human Chorionic Gonadotrophin (HCG). This hormone coats the cancer cells and makes them impervious to the immune system and thus making it hard for the immune system to do its job to kill the cancer cells. No other type of adult cell produces HCG, and a simple urine test can determine your HCG.
Butyrate or Butyric Acid as it is known, is a naturally occurring short-chain fatty acid which is found in the gut of humans and is created by the fermentation of fiber by gut bacteria. When butyrate is added as a cancer treatment protocol it is normally done adjunctively with other treatments like low dose chemotherapy or artemisin. Its effects have be proven to be demonstrated on colon and breast cancer cell lines by inducing apotosis (cell death) to cancer cells and changing the cells epigenetically to reduce their growth. Adding Butyrate to a regime is dependent on the cancer type and sensitivity testing done on the cancer.
Treatments with the thymus peptides involve taking extracts of thymus gland from animal sources. The thymus gland is an important gland in moderating the entire immune response to pathogens and defective cells. As we age the thymus shrinks in size and therefore its function is compromised and we are more at risk of cancer. Various factors can accelerate the weakening of the thymus gland, and they include malnutrition, repeated infections and chemotherapy and radiotherapy treatments. Taking thymus extracts or peptides helps increase the activity of the body’s own thymus gland by activating the white blood cells to be more active against cancer.
Spleen peptides are sourced from animal sources of spleen. The spleen gland is the largest gland of the lymphatic system and is a reservoir for white blood cells for assisting in activating an immune response in the body. Peptides of the spleen have been shown in research to be particularly effective in activating an immune response of the NK cells (natural killer cells) which are responsible for seeking out cancer cells and triggering cancer cell death. Peptide therapy can be combined with conventional treatments as a means to reducing the side effects of the therapy whilst at the same time helping to optimize the conventional treatments against cancer.
Treatments with peptides can also be given as IV infusions if needed.
With cancer patients we commonly find that there are multiple deficiencies all happening at the same time and we find that from research the biggest impact on a weakened immune system is the deficiency of key nutrients.
An appropriate supplement regimen can help reduce the toxicity of conventional therapy and contribute to your overall quality of life.
If you are receiving conventional treatment, it is also very important that your supplements do not interfere with the effectiveness of conventional treatments. If supplements oppose the action of chemotherapy or interact with either the uptake or elimination of a drug then they may not be safe.
Even after the right supplements are chosen, you will still need advice about dosage and the exact product to take.
